In a meta-analysis performed by Yuan et al. [58] on 794 ovarian cancer patients to determine the correlation between TAMs phenotype and clinical outcomes, infiltration of tumor tissue with CD163+ TAMs was associated with poor prognosis, while a high M1-to-M2 macrophage ratio predicted better prognosis for both OS and PFS. The gene discussed is CD163; the disease is ovarian carcinoma.